Brasada Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,985	Closed	-$514K	–	306
2018 Q1	$514K	Sell	4,985 -467	-9%	-$48.2K	0.16%	111
2017 Q4	$466K	Buy	+5,452	New	+$466K	0.16%	106